期刊
CLINICAL NEUROPHARMACOLOGY
卷 30, 期 5, 页码 276-280出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/WNF.0B013E318050C9F9
关键词
Parkinson disease; hormonal replacement therapy; dyskinesia
Eleven postmenopausal women with Parkinson disease and levodopa-induced peak-dose dyskinesias underwent a double-blind, placebo-controlled, crossover study. The active treatment consisted of estrogen replacement therapy for 12 weeks, followed by medroxyprogesterone acetate for 2 weeks. Estrogen replacement therapy-medroxyprogesterone acetate administration significantly improved peak dose dyskinesia without worsening motor disability, thus suggesting a possible benefit on dyskinesias in postmenopausal Women with Parkinson disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据